The solvent at antigen-binding site regulated C3d–CR2 interactions through the C-terminal tail of C3d at different ion strengths: insights from molecular dynamics simulation

The interactions of complement receptor 2 (CR2) and the degradation fragment C3d of complement component C3 play important links between the innate and adaptive immune systems. Due to the importance of C3d–CR2 interaction in the design of vaccines and inhibitors, a number of studies have been perfor...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta Vol. 1860; no. 10; pp. 2220 - 2231
Main Authors Zhang, Yan, Guo, Jingjing, Li, Lanlan, Liu, Xuewei, Yao, Xiaojun, Liu, Huanxiang
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.10.2016
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The interactions of complement receptor 2 (CR2) and the degradation fragment C3d of complement component C3 play important links between the innate and adaptive immune systems. Due to the importance of C3d–CR2 interaction in the design of vaccines and inhibitors, a number of studies have been performed to investigate C3d–CR2 interaction. Many studies have indicated C3d–CR2 interactions are ionic strength-dependent. To investigate the molecular mechanism of C3d–CR2 interaction and the origin of effects of ionic strength, molecular dynamics simulations for C3d–CR2 complex together with the energetic and structural analysis were performed. Our results revealed the increased interactions between charged protein and ions weaken C3d–CR2 association, as ionic strengths increase. Moreover, ion strengths have similar effects on antigen-binding site and CR2 binding site. Meanwhile, Ala17 and Gln20 will transform between the activated and non-activated states mediated by His133 and Glu135 at different ion strengths. Our results reveal the origins of the effects of ionic strengths on C3d–CR2 interactions are due to the changes of water, ion occupancies and distributions. This study uncovers the origin of the effect of ionic strength on C3d–CR2 interaction and deepens the understanding of the molecular mechanism of their interaction, which is valuable for the design of vaccines and small molecule inhibitors. [Display omitted] •The solvent occupancies and distributions at antigen-binding site are largely influenced by ionic strengths.•High ionic strengths enhances polar interactions of antigen-binding site and leads to the deviation of Lys291-Pro294 from CR2.•Lys291-Pro294 regulates the interdomain contact region of V-shape structure of CR2.•Ala17 and Gln20 transforms between the activated and non-activated states mediated by His133 and Glu135.
AbstractList BACKGROUNDThe interactions of complement receptor 2 (CR2) and the degradation fragment C3d of complement component C3 play important links between the innate and adaptive immune systems. Due to the importance of C3d-CR2 interaction in the design of vaccines and inhibitors, a number of studies have been performed to investigate C3d-CR2 interaction. Many studies have indicated C3d-CR2 interactions are ionic strength-dependent.METHODSTo investigate the molecular mechanism of C3d-CR2 interaction and the origin of effects of ionic strength, molecular dynamics simulations for C3d-CR2 complex together with the energetic and structural analysis were performed.RESULTSOur results revealed the increased interactions between charged protein and ions weaken C3d-CR2 association, as ionic strengths increase. Moreover, ion strengths have similar effects on antigen-binding site and CR2 binding site. Meanwhile, Ala17 and Gln20 will transform between the activated and non-activated states mediated by His133 and Glu135 at different ion strengths.CONCLUSIONSOur results reveal the origins of the effects of ionic strengths on C3d-CR2 interactions are due to the changes of water, ion occupancies and distributions.GENERAL SIGNIFICANCEThis study uncovers the origin of the effect of ionic strength on C3d-CR2 interaction and deepens the understanding of the molecular mechanism of their interaction, which is valuable for the design of vaccines and small molecule inhibitors.
The interactions of complement receptor 2 (CR2) and the degradation fragment C3d of complement component C3 play important links between the innate and adaptive immune systems. Due to the importance of C3d–CR2 interaction in the design of vaccines and inhibitors, a number of studies have been performed to investigate C3d–CR2 interaction. Many studies have indicated C3d–CR2 interactions are ionic strength-dependent. To investigate the molecular mechanism of C3d–CR2 interaction and the origin of effects of ionic strength, molecular dynamics simulations for C3d–CR2 complex together with the energetic and structural analysis were performed. Our results revealed the increased interactions between charged protein and ions weaken C3d–CR2 association, as ionic strengths increase. Moreover, ion strengths have similar effects on antigen-binding site and CR2 binding site. Meanwhile, Ala17 and Gln20 will transform between the activated and non-activated states mediated by His133 and Glu135 at different ion strengths. Our results reveal the origins of the effects of ionic strengths on C3d–CR2 interactions are due to the changes of water, ion occupancies and distributions. This study uncovers the origin of the effect of ionic strength on C3d–CR2 interaction and deepens the understanding of the molecular mechanism of their interaction, which is valuable for the design of vaccines and small molecule inhibitors. [Display omitted] •The solvent occupancies and distributions at antigen-binding site are largely influenced by ionic strengths.•High ionic strengths enhances polar interactions of antigen-binding site and leads to the deviation of Lys291-Pro294 from CR2.•Lys291-Pro294 regulates the interdomain contact region of V-shape structure of CR2.•Ala17 and Gln20 transforms between the activated and non-activated states mediated by His133 and Glu135.
The interactions of complement receptor 2 (CR2) and the degradation fragment C3d of complement component C3 play important links between the innate and adaptive immune systems. Due to the importance of C3d-CR2 interaction in the design of vaccines and inhibitors, a number of studies have been performed to investigate C3d-CR2 interaction. Many studies have indicated C3d-CR2 interactions are ionic strength-dependent. To investigate the molecular mechanism of C3d-CR2 interaction and the origin of effects of ionic strength, molecular dynamics simulations for C3d-CR2 complex together with the energetic and structural analysis were performed. Our results revealed the increased interactions between charged protein and ions weaken C3d-CR2 association, as ionic strengths increase. Moreover, ion strengths have similar effects on antigen-binding site and CR2 binding site. Meanwhile, Ala17 and Gln20 will transform between the activated and non-activated states mediated by His133 and Glu135 at different ion strengths. Our results reveal the origins of the effects of ionic strengths on C3d-CR2 interactions are due to the changes of water, ion occupancies and distributions. This study uncovers the origin of the effect of ionic strength on C3d-CR2 interaction and deepens the understanding of the molecular mechanism of their interaction, which is valuable for the design of vaccines and small molecule inhibitors.
The interactions of complement receptor 2 (CR2) and the degradation fragment C3d of complement component C3 play important links between the innate and adaptive immune systems. Due to the importance of C3d–CR2 interaction in the design of vaccines and inhibitors, a number of studies have been performed to investigate C3d–CR2 interaction. Many studies have indicated C3d–CR2 interactions are ionic strength-dependent.To investigate the molecular mechanism of C3d–CR2 interaction and the origin of effects of ionic strength, molecular dynamics simulations for C3d–CR2 complex together with the energetic and structural analysis were performed.Our results revealed the increased interactions between charged protein and ions weaken C3d–CR2 association, as ionic strengths increase. Moreover, ion strengths have similar effects on antigen-binding site and CR2 binding site. Meanwhile, Ala17 and Gln20 will transform between the activated and non-activated states mediated by His133 and Glu135 at different ion strengths.Our results reveal the origins of the effects of ionic strengths on C3d–CR2 interactions are due to the changes of water, ion occupancies and distributions.This study uncovers the origin of the effect of ionic strength on C3d–CR2 interaction and deepens the understanding of the molecular mechanism of their interaction, which is valuable for the design of vaccines and small molecule inhibitors.
Author Guo, Jingjing
Liu, Huanxiang
Zhang, Yan
Li, Lanlan
Liu, Xuewei
Yao, Xiaojun
Author_xml – sequence: 1
  givenname: Yan
  surname: Zhang
  fullname: Zhang, Yan
  organization: School of Pharmacy, Lanzhou University, Lanzhou 730000, PR China
– sequence: 2
  givenname: Jingjing
  surname: Guo
  fullname: Guo, Jingjing
  organization: School of Pharmacy, Lanzhou University, Lanzhou 730000, PR China
– sequence: 3
  givenname: Lanlan
  surname: Li
  fullname: Li, Lanlan
  organization: State Key Laboratory of Applied Organic Chemistry and Department of Chemistry, Lanzhou University, Lanzhou 730000, PR China
– sequence: 4
  givenname: Xuewei
  surname: Liu
  fullname: Liu, Xuewei
  organization: State Key Laboratory of Applied Organic Chemistry and Department of Chemistry, Lanzhou University, Lanzhou 730000, PR China
– sequence: 5
  givenname: Xiaojun
  surname: Yao
  fullname: Yao, Xiaojun
  organization: State Key Laboratory of Applied Organic Chemistry and Department of Chemistry, Lanzhou University, Lanzhou 730000, PR China
– sequence: 6
  givenname: Huanxiang
  surname: Liu
  fullname: Liu, Huanxiang
  email: hxliu@lzu.edu.cn
  organization: School of Pharmacy, Lanzhou University, Lanzhou 730000, PR China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27154286$$D View this record in MEDLINE/PubMed
BookMark eNqNkc9qFTEUxoNU7G31DUSydDPXJJOZyXQhyKX-gYIgdR0yycncXGaSmmQK3fkOPkjfyScx460uXKghkIR8v-8czneGTnzwgNBzSraU0PbVYTsMagS_ZeW1Jc2WEPYIbajoWCUIaU_QhtSEV5y2zSk6S-lAymr65gk6ZR1tOBPtBt1f7wGnMN2Cz1iV7bMrptXgvHF-xMllwBHGZVIZDN7V5vvXb7tPDDufISqdXfAJ530My7gvJ-BdVT5m59WEs3ITDnalVm_jrIW4FioQTrlcx7xPF8UruXGfE7YxzHgOE-hSL2Jz59XsdCpdzGsDBXuKHls1JXj2cJ6jz28vr3fvq6uP7z7s3lxVuu6bXFlBezNo1UFfC2iEEnboBq2HriaE113PNO-FbYAO3HCtuFKWaKN62_KOANTn6OXR9yaGLwukLGeXNEyT8hCWJKlgDa9Zy-v_kJKOCcKoKNIXD9JlmMHIm-hmFe_krzyKgB8FOoaUItjfEkrkGrs8yGPsco1dkkaW2At28QemXf45rxxLBv-CXx9hKPO8dRBl0g68BuMi6CxNcH83-AEKcs7-
CitedBy_id crossref_primary_10_1016_j_dci_2023_105109
crossref_primary_10_1111_cbdd_13460
crossref_primary_10_1111_cbdd_13045
crossref_primary_10_3390_biom13030443
crossref_primary_10_1021_acsnano_6b05536
Cites_doi 10.1002/jcc.20290
10.1039/C2CP41388D
10.4049/jimmunol.172.12.7537
10.1146/annurev.bb.18.060189.002243
10.1126/science.271.5247.348
10.1002/ange.200462957
10.1063/1.470117
10.1073/pnas.0704459104
10.1002/prot.10470
10.4049/jimmunol.147.2.590
10.1371/journal.pcbi.1002840
10.1016/j.jmb.2007.02.101
10.1016/j.jmb.2004.10.017
10.1016/j.molimm.2014.11.006
10.1063/1.448118
10.1021/ci300375k
10.1529/biophysj.105.068130
10.1021/ja981844+
10.1021/ct700119m
10.1034/j.1600-065X.2001.1800103.x
10.4049/jimmunol.167.3.1490
10.1021/mp900131p
10.1016/S0022-2836(03)00610-7
10.1074/jbc.M808404200
10.1002/prot.21123
10.1073/pnas.84.24.9194
10.1006/jmbi.1993.1381
10.1126/science.1201954
10.1002/j.1460-2075.1991.tb08025.x
10.1021/ci100275a
10.1016/j.immuni.2012.08.002
10.1002/bip.10270
10.4049/jimmunol.141.8.2569
10.1021/acs.jmedchem.5b01062
10.1016/0092-8674(89)90240-7
10.1093/emboj/18.22.6228
10.1021/j100058a043
10.1126/science.280.5367.1277
10.1093/emboj/18.11.2911
10.1038/358505a0
10.1128/JVI.62.4.1442-1447.1988
10.1084/jem.140.1.126
10.1084/jem.158.4.1021
10.1146/annurev.immunol.16.1.545
10.1021/bi0101749
10.1084/jem.167.3.1047
10.1016/0021-9991(77)90098-5
10.1128/JVI.01673-08
10.1021/ar00161a004
10.1002/jcc.10349
10.1021/ar000033j
10.1063/1.445869
ContentType Journal Article
Copyright 2016 Elsevier B.V.
Copyright © 2016 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2016 Elsevier B.V.
– notice: Copyright © 2016 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7S9
L.6
DOI 10.1016/j.bbagen.2016.05.002
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AGRICOLA
AGRICOLA - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE
AGRICOLA
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
Biology
EISSN 1872-8006
EndPage 2231
ExternalDocumentID 27154286
10_1016_j_bbagen_2016_05_002
S0304416516301313
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8P~
9JM
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AAXUO
ABEFU
ABFNM
ABGSF
ABMAC
ABUDA
ABXDB
ABYKQ
ACDAQ
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEHWI
AEKER
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
CS3
DOVZS
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HLW
HVGLF
HZ~
IHE
J1W
KOM
LX3
M41
MO0
N9A
O-L
O9-
OAUVE
OHT
OZT
P-8
P-9
PC.
Q38
R2-
ROL
RPZ
SBG
SCC
SDF
SDG
SDP
SES
SEW
SPCBC
SSU
SSZ
T5K
UQL
WH7
WUQ
XJT
XPP
~G-
AAHBH
AATTM
AAXKI
AAYWO
AAYXX
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
AEIPS
AEUPX
AFJKZ
AFPUW
AGCQF
AGQPQ
AGRNS
AIGII
AIIUN
AKBMS
AKRWK
AKYEP
ANKPU
APXCP
BNPGV
CITATION
SSH
-~X
.55
.GJ
AAYJJ
ABJNI
AFFNX
AI.
CGR
CUY
CVF
ECM
EIF
F5P
H~9
K-O
MVM
NPM
RIG
TWZ
UHS
VH1
X7M
Y6R
YYP
ZE2
ZGI
~KM
7X8
7S9
EFKBS
L.6
ID FETCH-LOGICAL-c395t-f819dbca7e938e58a8fb7bccb730043792c498f5e1b4d4ca4aaf0cda9f6470ee3
IEDL.DBID .~1
ISSN 0304-4165
0006-3002
IngestDate Tue Aug 05 10:54:34 EDT 2025
Thu Jul 10 18:42:14 EDT 2025
Thu Apr 03 07:09:30 EDT 2025
Thu Apr 24 23:04:11 EDT 2025
Tue Jul 01 00:22:06 EDT 2025
Fri Feb 23 02:34:16 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords CR2
Complement
Molecular dynamics simulation
C3d
MM-GBSA
Language English
License Copyright © 2016 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c395t-f819dbca7e938e58a8fb7bccb730043792c498f5e1b4d4ca4aaf0cda9f6470ee3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 27154286
PQID 1807280218
PQPubID 23479
PageCount 12
ParticipantIDs proquest_miscellaneous_1825432643
proquest_miscellaneous_1807280218
pubmed_primary_27154286
crossref_primary_10_1016_j_bbagen_2016_05_002
crossref_citationtrail_10_1016_j_bbagen_2016_05_002
elsevier_sciencedirect_doi_10_1016_j_bbagen_2016_05_002
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate October 2016
2016-10-00
20161001
PublicationDateYYYYMMDD 2016-10-01
PublicationDate_xml – month: 10
  year: 2016
  text: October 2016
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Biochimica et biophysica acta
PublicationTitleAlternate Biochim Biophys Acta
PublicationYear 2016
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Kovacs, Hannan, Eisenmesser, Holers (bb0240) 2009; 284
Zhang, Mallik, Morikis (bb0090) 2007; 369
Morikis, Lambris (bb0115) 2004; 172
Srinivasan, Cheatham, Cieplak, Kollman, Case (bb0205) 1998; 120
Wan, Hu, Tian, Chang (bb0260) 2013; 15
Moore, Cooper, Tack, Nemerow (bb0030) 1987; 84
Hou, Wang, Li, Wang (bb0185) 2011; 51
Gorham, Nuñez, Lin, Rooijakkers, Vullev, Morikis (bb0100) 2015; 58
Pepys (bb0050) 1974; 140
Lange, Grubmüller, De Groot (bb0230) 2005; 117
Jorgensen, Chandrasekhar, Madura, Impey, Klein (bb0145) 1983; 79
Guthridge, Rakstang, Young, Hinshelwood, Aslam, Robertson, Gipson, Sarrias, Moore, Meagher (bb0110) 2001; 40
Ghosh, Vishveshwara (bb0235) 2007; 104
Fingeroth, Clabby, Strominger (bb0040) 1988; 62
Li, Li, Zhang, Hou (bb0200) 2012; 52
Kalli, Ahearn, Fearon (bb0010) 1991; 147
Gouda, Kuntz, Case, Kollman (bb0175) 2003; 68
Schwarzenbacher, Zeth, Diederichs, Gries, Kostner, Laggner, Prassl (bb0130) 1999; 18
Delcayre, Salas, Mathur, Kovats, Lotz, Lernhardt (bb0075) 1991; 10
Lee, Duan (bb0215) 2004; 55
Nagar, Jones, Diefenbach, Isenman, Rini (bb0015) 1998; 280
Iida, Nadler, Nussenzweig (bb0060) 1983; 158
Sahu, Lambris (bb0005) 2001; 180
Barlow, Steinkasserer, Norman, Kieffer, Wiles, Sim, Campbell (bb0120) 1993; 232
Kollman, Massova, Reyes, Kuhn, Huo, Chong, Lee, Lee, Duan, Wang (bb0210) 2000; 33
Nemerow, Houghten, Moore, Cooper (bb0070) 1989; 56
Mohan, Gorham, Morikis (bb0255) 2015; 64
Dempsey, Allison, Akkaraju, Goodnow, Fearon (bb0020) 1996; 271
Carroll (bb0055) 1998; 16
van den Elsen, Isenman (bb0085) 2011; 332
Duan, Wu, Chowdhury, Lee, Xiong, Zhang, Yang, Cieplak, Luo, Lee (bb0180) 2003; 24
Ryckaert, Ciccotti, Berendsen (bb0155) 1977; 23
Zhang, Morikis (bb0250) 2006; 90
Jorgensen (bb0170) 1989; 22
Gohlke, Kiel, Case (bb0195) 2003; 330
Kieslich, Morikis (bb0095) 2012; 8
Carroll, Isenman (bb0025) 2012; 37
Beveridge, DiCapua (bb0165) 1989; 18
Sarrias, Franchini, Canziani, Argyropoulos, Moore, Sahu, Lambris (bb0105) 2001; 167
Bohnsack, Cooper (bb0080) 1988; 141
Berendsen, Postma, van Gunsteren, DiNola, Haak (bb0160) 1984; 81
Lehtinen, Meri, Jokiranta (bb0125) 2004; 344
Liu, Yao (bb0190) 2009; 7
Aubry, Pochon, Graber, Jansen, Bonnefoy (bb0065) 1992; 358
Essmann, Perera, Berkowitz, Darden, Lee, Pedersen (bb0150) 1995; 103
Young, Herbert, Barlow, Holers, Hannan (bb0245) 2008; 82
Weis, Toothaker, Smith, Weis, Fearon (bb0035) 1988; 167
Hornak, Abel, Okur, Strockbine, Roitberg, Simmerling (bb0140) 2006; 65
Case, Cheatham, Darden, Gohlke, Luo, Merz, Onufriev, Simmerling, Wang, Woods (bb0135) 2005; 26
Sitkoff, Sharp, Honig (bb0220) 1994; 98
Shao, Tanner, Thompson, Cheatham (bb0225) 2007; 3
Casasnovas, Larvie, Stehle (bb0045) 1999; 18
Shao (10.1016/j.bbagen.2016.05.002_bb0225) 2007; 3
Zhang (10.1016/j.bbagen.2016.05.002_bb0090) 2007; 369
Kollman (10.1016/j.bbagen.2016.05.002_bb0210) 2000; 33
Kieslich (10.1016/j.bbagen.2016.05.002_bb0095) 2012; 8
Kovacs (10.1016/j.bbagen.2016.05.002_bb0240) 2009; 284
Hornak (10.1016/j.bbagen.2016.05.002_bb0140) 2006; 65
Duan (10.1016/j.bbagen.2016.05.002_bb0180) 2003; 24
Berendsen (10.1016/j.bbagen.2016.05.002_bb0160) 1984; 81
Fingeroth (10.1016/j.bbagen.2016.05.002_bb0040) 1988; 62
Casasnovas (10.1016/j.bbagen.2016.05.002_bb0045) 1999; 18
Schwarzenbacher (10.1016/j.bbagen.2016.05.002_bb0130) 1999; 18
Iida (10.1016/j.bbagen.2016.05.002_bb0060) 1983; 158
Aubry (10.1016/j.bbagen.2016.05.002_bb0065) 1992; 358
Mohan (10.1016/j.bbagen.2016.05.002_bb0255) 2015; 64
Moore (10.1016/j.bbagen.2016.05.002_bb0030) 1987; 84
Delcayre (10.1016/j.bbagen.2016.05.002_bb0075) 1991; 10
Nagar (10.1016/j.bbagen.2016.05.002_bb0015) 1998; 280
Wan (10.1016/j.bbagen.2016.05.002_bb0260) 2013; 15
Sarrias (10.1016/j.bbagen.2016.05.002_bb0105) 2001; 167
Gouda (10.1016/j.bbagen.2016.05.002_bb0175) 2003; 68
Lange (10.1016/j.bbagen.2016.05.002_bb0230) 2005; 117
Dempsey (10.1016/j.bbagen.2016.05.002_bb0020) 1996; 271
Case (10.1016/j.bbagen.2016.05.002_bb0135) 2005; 26
Ghosh (10.1016/j.bbagen.2016.05.002_bb0235) 2007; 104
Jorgensen (10.1016/j.bbagen.2016.05.002_bb0145) 1983; 79
Guthridge (10.1016/j.bbagen.2016.05.002_bb0110) 2001; 40
Zhang (10.1016/j.bbagen.2016.05.002_bb0250) 2006; 90
Gorham (10.1016/j.bbagen.2016.05.002_bb0100) 2015; 58
Bohnsack (10.1016/j.bbagen.2016.05.002_bb0080) 1988; 141
Beveridge (10.1016/j.bbagen.2016.05.002_bb0165) 1989; 18
Li (10.1016/j.bbagen.2016.05.002_bb0200) 2012; 52
Ryckaert (10.1016/j.bbagen.2016.05.002_bb0155) 1977; 23
Essmann (10.1016/j.bbagen.2016.05.002_bb0150) 1995; 103
Sahu (10.1016/j.bbagen.2016.05.002_bb0005) 2001; 180
Gohlke (10.1016/j.bbagen.2016.05.002_bb0195) 2003; 330
Kalli (10.1016/j.bbagen.2016.05.002_bb0010) 1991; 147
Nemerow (10.1016/j.bbagen.2016.05.002_bb0070) 1989; 56
Young (10.1016/j.bbagen.2016.05.002_bb0245) 2008; 82
Hou (10.1016/j.bbagen.2016.05.002_bb0185) 2011; 51
Pepys (10.1016/j.bbagen.2016.05.002_bb0050) 1974; 140
Jorgensen (10.1016/j.bbagen.2016.05.002_bb0170) 1989; 22
Liu (10.1016/j.bbagen.2016.05.002_bb0190) 2009; 7
Lehtinen (10.1016/j.bbagen.2016.05.002_bb0125) 2004; 344
Weis (10.1016/j.bbagen.2016.05.002_bb0035) 1988; 167
Srinivasan (10.1016/j.bbagen.2016.05.002_bb0205) 1998; 120
Barlow (10.1016/j.bbagen.2016.05.002_bb0120) 1993; 232
Carroll (10.1016/j.bbagen.2016.05.002_bb0025) 2012; 37
van den Elsen (10.1016/j.bbagen.2016.05.002_bb0085) 2011; 332
Morikis (10.1016/j.bbagen.2016.05.002_bb0115) 2004; 172
Carroll (10.1016/j.bbagen.2016.05.002_bb0055) 1998; 16
Sitkoff (10.1016/j.bbagen.2016.05.002_bb0220) 1994; 98
Lee (10.1016/j.bbagen.2016.05.002_bb0215) 2004; 55
References_xml – volume: 140
  start-page: 126
  year: 1974
  end-page: 145
  ident: bb0050
  article-title: Role of complement in induction of antibody production in vivo Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses
  publication-title: J. Exp. Med.
– volume: 8
  year: 2012
  ident: bb0095
  article-title: The two sides of complement C3d: evolution of electrostatics in a link between innate and adaptive immunity
  publication-title: PLoS Comput. Biol.
– volume: 65
  start-page: 712
  year: 2006
  end-page: 725
  ident: bb0140
  article-title: Comparison of multiple amber force fields and development of improved protein backbone parameters
  publication-title: Proteins Struct. Funct. Bioinform.
– volume: 344
  start-page: 1385
  year: 2004
  end-page: 1396
  ident: bb0125
  article-title: Interdomain contact regions and angles between adjacent short consensus repeat domains
  publication-title: J. Mol. Biol.
– volume: 51
  start-page: 69
  year: 2011
  end-page: 82
  ident: bb0185
  article-title: Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations
  publication-title: J. Chem. Inf. Model.
– volume: 141
  start-page: 2569
  year: 1988
  end-page: 2576
  ident: bb0080
  article-title: CR2 ligands modulate human B cell activation
  publication-title: J. Immunol.
– volume: 167
  start-page: 1490
  year: 2001
  end-page: 1499
  ident: bb0105
  article-title: Kinetic analysis of the interactions of complement receptor 2 (cr2, cd21) with its ligands c3d, ic3b, and the ebv glycoprotein gp350/220
  publication-title: J. Immunol.
– volume: 18
  start-page: 2911
  year: 1999
  end-page: 2922
  ident: bb0045
  article-title: Crystal structure of two CD46 domains reveals an extended measles virus-binding surface
  publication-title: EMBO J.
– volume: 56
  start-page: 369
  year: 1989
  end-page: 377
  ident: bb0070
  article-title: Identification of an epitope in the major envelope protein of Epstein–Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2)
  publication-title: Cell
– volume: 18
  start-page: 431
  year: 1989
  end-page: 492
  ident: bb0165
  article-title: Free energy via molecular simulation: applications to chemical and biomolecular systems
  publication-title: Annu. Rev. Biophys. Biophys. Chem.
– volume: 23
  start-page: 327
  year: 1977
  end-page: 341
  ident: bb0155
  article-title: Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes
  publication-title: J. Comput. Phys.
– volume: 332
  start-page: 608
  year: 2011
  end-page: 611
  ident: bb0085
  article-title: A crystal structure of the complex between human complement receptor 2 and its ligand C3d
  publication-title: Science
– volume: 120
  start-page: 9401
  year: 1998
  end-page: 9409
  ident: bb0205
  article-title: Continuum solvent studies of the stability of DNA, rna, and phosphoramidate-DNA helices
  publication-title: J. Am. Chem. Soc.
– volume: 18
  start-page: 6228
  year: 1999
  end-page: 6239
  ident: bb0130
  article-title: Crystal structure of human β2-glycoprotein i: implications for phospholipid binding and the antiphospholipid syndrome
  publication-title: EMBO J.
– volume: 84
  start-page: 9194
  year: 1987
  end-page: 9198
  ident: bb0030
  article-title: Molecular cloning of the cDNA encoding the Epstein–Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes
  publication-title: Proc. Natl. Acad. Sci.
– volume: 330
  start-page: 891
  year: 2003
  end-page: 913
  ident: bb0195
  article-title: Insights into protein–protein binding by binding free energy calculation and free energy decomposition for the ras–raf and ras–ralgds complexes
  publication-title: J. Mol. Biol.
– volume: 180
  start-page: 35
  year: 2001
  end-page: 48
  ident: bb0005
  article-title: Structure and biology of complement protein C3, a connecting link between innate and acquired immunity
  publication-title: Immunol. Rev.
– volume: 40
  start-page: 5931
  year: 2001
  end-page: 5941
  ident: bb0110
  article-title: Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg
  publication-title: Biochemistry
– volume: 24
  start-page: 1999
  year: 2003
  end-page: 2012
  ident: bb0180
  article-title: A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations
  publication-title: J. Comput. Chem.
– volume: 79
  start-page: 926
  year: 1983
  end-page: 935
  ident: bb0145
  article-title: Comparison of simple potential functions for simulating liquid water
  publication-title: J. Chem. Phys.
– volume: 90
  start-page: 3106
  year: 2006
  end-page: 3119
  ident: bb0250
  article-title: Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics
  publication-title: Biophys. J.
– volume: 81
  start-page: 3684
  year: 1984
  end-page: 3690
  ident: bb0160
  article-title: Molecular dynamics with coupling to an external bath
  publication-title: J. Chem. Phys.
– volume: 52
  start-page: 2715
  year: 2012
  end-page: 2729
  ident: bb0200
  article-title: Theoretical studies on the susceptibility of oseltamivir against variants of 2009 a/h1n1 influenza neuraminidase
  publication-title: J. Chem. Inf. Model.
– volume: 68
  start-page: 16
  year: 2003
  end-page: 34
  ident: bb0175
  article-title: Free energy calculations for theophylline binding to an rna aptamer: comparison of mm-pbsa and thermodynamic integration methods
  publication-title: Biopolymers
– volume: 98
  start-page: 1978
  year: 1994
  end-page: 1988
  ident: bb0220
  article-title: Accurate calculation of hydration free energies using macroscopic solvent models
  publication-title: J. Phys. Chem.
– volume: 147
  start-page: 590
  year: 1991
  end-page: 594
  ident: bb0010
  article-title: Interaction of iC3b with recombinant isotypic and chimeric forms of CR2
  publication-title: J. Immunol.
– volume: 7
  start-page: 75
  year: 2009
  end-page: 85
  ident: bb0190
  article-title: Molecular basis of the interaction for an essential subunit pa
  publication-title: Mol. Pharm.
– volume: 62
  start-page: 1442
  year: 1988
  end-page: 1447
  ident: bb0040
  article-title: Characterization of a T-lymphocyte Epstein–Barr virus/C3d receptor (CD21)
  publication-title: J. Virol.
– volume: 55
  start-page: 620
  year: 2004
  end-page: 634
  ident: bb0215
  article-title: Distinguish protein decoys by using a scoring function based on a new amber force field, short molecular dynamics simulations, and the generalized born solvent model
  publication-title: Proteins Struct. Funct. Bioinform.
– volume: 369
  start-page: 567
  year: 2007
  end-page: 583
  ident: bb0090
  article-title: Immunophysical exploration of C3d–CR2(CCP1-2) interaction using molecular dynamics and electrostatics
  publication-title: J. Mol. Biol.
– volume: 280
  start-page: 1277
  year: 1998
  end-page: 1281
  ident: bb0015
  article-title: X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2
  publication-title: Science
– volume: 167
  start-page: 1047
  year: 1988
  end-page: 1066
  ident: bb0035
  article-title: Structure of the human B lymphocyte receptor for C3d and the Epstein–Barr virus and relatedness to other members of the family of C3/C4 binding proteins
  publication-title: J. Exp. Med.
– volume: 232
  start-page: 268
  year: 1993
  end-page: 284
  ident: bb0120
  article-title: Solution structure of a pair of complement modules by nuclear magnetic resonance
  publication-title: J. Mol. Biol.
– volume: 15
  start-page: 1241
  year: 2013
  end-page: 1251
  ident: bb0260
  article-title: Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d
  publication-title: Phys. Chem. Chem. Phys.
– volume: 64
  start-page: 112
  year: 2015
  end-page: 122
  ident: bb0255
  article-title: A theoretical view of the c3d:Cr2 binding controversy
  publication-title: Mol. Immunol.
– volume: 82
  start-page: 11217
  year: 2008
  end-page: 11227
  ident: bb0245
  article-title: Molecular basis of the interaction between complement receptor type 2 (cr2/cd21) and Epstein–Barr virus glycoprotein gp350
  publication-title: J. Virol.
– volume: 117
  start-page: 3460
  year: 2005
  end-page: 3465
  ident: bb0230
  article-title: Molecular dynamics simulations of protein g challenge nmr-derived correlated backbone motions
  publication-title: Angew. Chem.
– volume: 22
  start-page: 184
  year: 1989
  end-page: 189
  ident: bb0170
  article-title: Free energy calculations: a breakthrough for modeling organic chemistry in solution
  publication-title: Acc. Chem. Res.
– volume: 26
  start-page: 1668
  year: 2005
  end-page: 1688
  ident: bb0135
  article-title: The amber biomolecular simulation programs
  publication-title: J. Comput. Chem.
– volume: 104
  start-page: 15711
  year: 2007
  end-page: 15716
  ident: bb0235
  article-title: A study of communication pathways in methionyl-trna synthetase by molecular dynamics simulations and structure network analysis
  publication-title: Proc. Natl. Acad. Sci.
– volume: 33
  start-page: 889
  year: 2000
  end-page: 897
  ident: bb0210
  article-title: Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models
  publication-title: Acc. Chem. Res.
– volume: 37
  start-page: 199
  year: 2012
  end-page: 207
  ident: bb0025
  article-title: Regulation of humoral immunity by complement
  publication-title: Immunity
– volume: 3
  start-page: 2312
  year: 2007
  end-page: 2334
  ident: bb0225
  article-title: Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms
  publication-title: J. Chem. Theory Comput.
– volume: 271
  start-page: 348
  year: 1996
  end-page: 349
  ident: bb0020
  article-title: C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
  publication-title: Science
– volume: 158
  start-page: 1021
  year: 1983
  end-page: 1033
  ident: bb0060
  article-title: Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody
  publication-title: J. Exp. Med.
– volume: 16
  start-page: 545
  year: 1998
  end-page: 568
  ident: bb0055
  article-title: The role of complement and complement receptors in induction and regulation of immunity
  publication-title: Annu. Rev. Immunol.
– volume: 358
  start-page: 505
  year: 1992
  end-page: 507
  ident: bb0065
  article-title: CD21 is a ligand for CD23 and regulates IgE production
  publication-title: Nature
– volume: 10
  start-page: 919
  year: 1991
  end-page: 926
  ident: bb0075
  article-title: Epstein Barr virus/complement C3d receptor is an interferon alpha receptor
  publication-title: EMBO J.
– volume: 103
  start-page: 8577
  year: 1995
  end-page: 8593
  ident: bb0150
  article-title: A smooth particle mesh ewald method
  publication-title: J. Chem. Phys.
– volume: 58
  start-page: 9535
  year: 2015
  end-page: 9545
  ident: bb0100
  article-title: Discovery of small molecules for fluorescent detection of complement activation product c3d
  publication-title: J. Med. Chem.
– volume: 172
  start-page: 7537
  year: 2004
  end-page: 7547
  ident: bb0115
  article-title: The electrostatic nature of c3d-complement receptor 2 association
  publication-title: J. Immunol.
– volume: 284
  start-page: 9513
  year: 2009
  end-page: 9520
  ident: bb0240
  article-title: Mapping of the c3d ligand binding site on complement receptor 2 (cr2/cd21) using nuclear magnetic resonance and chemical shift analysis
  publication-title: J. Biol. Chem.
– volume: 26
  start-page: 1668
  year: 2005
  ident: 10.1016/j.bbagen.2016.05.002_bb0135
  article-title: The amber biomolecular simulation programs
  publication-title: J. Comput. Chem.
  doi: 10.1002/jcc.20290
– volume: 15
  start-page: 1241
  year: 2013
  ident: 10.1016/j.bbagen.2016.05.002_bb0260
  article-title: Molecular dynamics simulations of wild type and mutants of human complement receptor 2 complexed with C3d
  publication-title: Phys. Chem. Chem. Phys.
  doi: 10.1039/C2CP41388D
– volume: 172
  start-page: 7537
  year: 2004
  ident: 10.1016/j.bbagen.2016.05.002_bb0115
  article-title: The electrostatic nature of c3d-complement receptor 2 association
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.172.12.7537
– volume: 18
  start-page: 431
  year: 1989
  ident: 10.1016/j.bbagen.2016.05.002_bb0165
  article-title: Free energy via molecular simulation: applications to chemical and biomolecular systems
  publication-title: Annu. Rev. Biophys. Biophys. Chem.
  doi: 10.1146/annurev.bb.18.060189.002243
– volume: 271
  start-page: 348
  year: 1996
  ident: 10.1016/j.bbagen.2016.05.002_bb0020
  article-title: C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
  publication-title: Science
  doi: 10.1126/science.271.5247.348
– volume: 117
  start-page: 3460
  year: 2005
  ident: 10.1016/j.bbagen.2016.05.002_bb0230
  article-title: Molecular dynamics simulations of protein g challenge nmr-derived correlated backbone motions
  publication-title: Angew. Chem.
  doi: 10.1002/ange.200462957
– volume: 103
  start-page: 8577
  year: 1995
  ident: 10.1016/j.bbagen.2016.05.002_bb0150
  article-title: A smooth particle mesh ewald method
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.470117
– volume: 104
  start-page: 15711
  year: 2007
  ident: 10.1016/j.bbagen.2016.05.002_bb0235
  article-title: A study of communication pathways in methionyl-trna synthetase by molecular dynamics simulations and structure network analysis
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.0704459104
– volume: 55
  start-page: 620
  year: 2004
  ident: 10.1016/j.bbagen.2016.05.002_bb0215
  article-title: Distinguish protein decoys by using a scoring function based on a new amber force field, short molecular dynamics simulations, and the generalized born solvent model
  publication-title: Proteins Struct. Funct. Bioinform.
  doi: 10.1002/prot.10470
– volume: 147
  start-page: 590
  year: 1991
  ident: 10.1016/j.bbagen.2016.05.002_bb0010
  article-title: Interaction of iC3b with recombinant isotypic and chimeric forms of CR2
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.147.2.590
– volume: 8
  year: 2012
  ident: 10.1016/j.bbagen.2016.05.002_bb0095
  article-title: The two sides of complement C3d: evolution of electrostatics in a link between innate and adaptive immunity
  publication-title: PLoS Comput. Biol.
  doi: 10.1371/journal.pcbi.1002840
– volume: 369
  start-page: 567
  year: 2007
  ident: 10.1016/j.bbagen.2016.05.002_bb0090
  article-title: Immunophysical exploration of C3d–CR2(CCP1-2) interaction using molecular dynamics and electrostatics
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2007.02.101
– volume: 344
  start-page: 1385
  year: 2004
  ident: 10.1016/j.bbagen.2016.05.002_bb0125
  article-title: Interdomain contact regions and angles between adjacent short consensus repeat domains
  publication-title: J. Mol. Biol.
  doi: 10.1016/j.jmb.2004.10.017
– volume: 64
  start-page: 112
  year: 2015
  ident: 10.1016/j.bbagen.2016.05.002_bb0255
  article-title: A theoretical view of the c3d:Cr2 binding controversy
  publication-title: Mol. Immunol.
  doi: 10.1016/j.molimm.2014.11.006
– volume: 81
  start-page: 3684
  year: 1984
  ident: 10.1016/j.bbagen.2016.05.002_bb0160
  article-title: Molecular dynamics with coupling to an external bath
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.448118
– volume: 52
  start-page: 2715
  year: 2012
  ident: 10.1016/j.bbagen.2016.05.002_bb0200
  article-title: Theoretical studies on the susceptibility of oseltamivir against variants of 2009 a/h1n1 influenza neuraminidase
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/ci300375k
– volume: 90
  start-page: 3106
  year: 2006
  ident: 10.1016/j.bbagen.2016.05.002_bb0250
  article-title: Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics
  publication-title: Biophys. J.
  doi: 10.1529/biophysj.105.068130
– volume: 120
  start-page: 9401
  year: 1998
  ident: 10.1016/j.bbagen.2016.05.002_bb0205
  article-title: Continuum solvent studies of the stability of DNA, rna, and phosphoramidate-DNA helices
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja981844+
– volume: 3
  start-page: 2312
  year: 2007
  ident: 10.1016/j.bbagen.2016.05.002_bb0225
  article-title: Clustering molecular dynamics trajectories: 1. Characterizing the performance of different clustering algorithms
  publication-title: J. Chem. Theory Comput.
  doi: 10.1021/ct700119m
– volume: 180
  start-page: 35
  year: 2001
  ident: 10.1016/j.bbagen.2016.05.002_bb0005
  article-title: Structure and biology of complement protein C3, a connecting link between innate and acquired immunity
  publication-title: Immunol. Rev.
  doi: 10.1034/j.1600-065X.2001.1800103.x
– volume: 167
  start-page: 1490
  year: 2001
  ident: 10.1016/j.bbagen.2016.05.002_bb0105
  article-title: Kinetic analysis of the interactions of complement receptor 2 (cr2, cd21) with its ligands c3d, ic3b, and the ebv glycoprotein gp350/220
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.167.3.1490
– volume: 7
  start-page: 75
  year: 2009
  ident: 10.1016/j.bbagen.2016.05.002_bb0190
  article-title: Molecular basis of the interaction for an essential subunit pa−pb1 in influenza virus rna polymerase: insights from molecular dynamics simulation and free energy calculation
  publication-title: Mol. Pharm.
  doi: 10.1021/mp900131p
– volume: 330
  start-page: 891
  year: 2003
  ident: 10.1016/j.bbagen.2016.05.002_bb0195
  article-title: Insights into protein–protein binding by binding free energy calculation and free energy decomposition for the ras–raf and ras–ralgds complexes
  publication-title: J. Mol. Biol.
  doi: 10.1016/S0022-2836(03)00610-7
– volume: 284
  start-page: 9513
  year: 2009
  ident: 10.1016/j.bbagen.2016.05.002_bb0240
  article-title: Mapping of the c3d ligand binding site on complement receptor 2 (cr2/cd21) using nuclear magnetic resonance and chemical shift analysis
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M808404200
– volume: 65
  start-page: 712
  year: 2006
  ident: 10.1016/j.bbagen.2016.05.002_bb0140
  article-title: Comparison of multiple amber force fields and development of improved protein backbone parameters
  publication-title: Proteins Struct. Funct. Bioinform.
  doi: 10.1002/prot.21123
– volume: 84
  start-page: 9194
  year: 1987
  ident: 10.1016/j.bbagen.2016.05.002_bb0030
  article-title: Molecular cloning of the cDNA encoding the Epstein–Barr virus/C3d receptor (complement receptor type 2) of human B lymphocytes
  publication-title: Proc. Natl. Acad. Sci.
  doi: 10.1073/pnas.84.24.9194
– volume: 232
  start-page: 268
  year: 1993
  ident: 10.1016/j.bbagen.2016.05.002_bb0120
  article-title: Solution structure of a pair of complement modules by nuclear magnetic resonance
  publication-title: J. Mol. Biol.
  doi: 10.1006/jmbi.1993.1381
– volume: 332
  start-page: 608
  year: 2011
  ident: 10.1016/j.bbagen.2016.05.002_bb0085
  article-title: A crystal structure of the complex between human complement receptor 2 and its ligand C3d
  publication-title: Science
  doi: 10.1126/science.1201954
– volume: 10
  start-page: 919
  year: 1991
  ident: 10.1016/j.bbagen.2016.05.002_bb0075
  article-title: Epstein Barr virus/complement C3d receptor is an interferon alpha receptor
  publication-title: EMBO J.
  doi: 10.1002/j.1460-2075.1991.tb08025.x
– volume: 51
  start-page: 69
  year: 2011
  ident: 10.1016/j.bbagen.2016.05.002_bb0185
  article-title: Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations
  publication-title: J. Chem. Inf. Model.
  doi: 10.1021/ci100275a
– volume: 37
  start-page: 199
  year: 2012
  ident: 10.1016/j.bbagen.2016.05.002_bb0025
  article-title: Regulation of humoral immunity by complement
  publication-title: Immunity
  doi: 10.1016/j.immuni.2012.08.002
– volume: 68
  start-page: 16
  year: 2003
  ident: 10.1016/j.bbagen.2016.05.002_bb0175
  article-title: Free energy calculations for theophylline binding to an rna aptamer: comparison of mm-pbsa and thermodynamic integration methods
  publication-title: Biopolymers
  doi: 10.1002/bip.10270
– volume: 141
  start-page: 2569
  year: 1988
  ident: 10.1016/j.bbagen.2016.05.002_bb0080
  article-title: CR2 ligands modulate human B cell activation
  publication-title: J. Immunol.
  doi: 10.4049/jimmunol.141.8.2569
– volume: 58
  start-page: 9535
  year: 2015
  ident: 10.1016/j.bbagen.2016.05.002_bb0100
  article-title: Discovery of small molecules for fluorescent detection of complement activation product c3d
  publication-title: J. Med. Chem.
  doi: 10.1021/acs.jmedchem.5b01062
– volume: 56
  start-page: 369
  year: 1989
  ident: 10.1016/j.bbagen.2016.05.002_bb0070
  article-title: Identification of an epitope in the major envelope protein of Epstein–Barr virus that mediates viral binding to the B lymphocyte EBV receptor (CR2)
  publication-title: Cell
  doi: 10.1016/0092-8674(89)90240-7
– volume: 18
  start-page: 6228
  year: 1999
  ident: 10.1016/j.bbagen.2016.05.002_bb0130
  article-title: Crystal structure of human β2-glycoprotein i: implications for phospholipid binding and the antiphospholipid syndrome
  publication-title: EMBO J.
  doi: 10.1093/emboj/18.22.6228
– volume: 98
  start-page: 1978
  year: 1994
  ident: 10.1016/j.bbagen.2016.05.002_bb0220
  article-title: Accurate calculation of hydration free energies using macroscopic solvent models
  publication-title: J. Phys. Chem.
  doi: 10.1021/j100058a043
– volume: 280
  start-page: 1277
  year: 1998
  ident: 10.1016/j.bbagen.2016.05.002_bb0015
  article-title: X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2
  publication-title: Science
  doi: 10.1126/science.280.5367.1277
– volume: 18
  start-page: 2911
  year: 1999
  ident: 10.1016/j.bbagen.2016.05.002_bb0045
  article-title: Crystal structure of two CD46 domains reveals an extended measles virus-binding surface
  publication-title: EMBO J.
  doi: 10.1093/emboj/18.11.2911
– volume: 358
  start-page: 505
  year: 1992
  ident: 10.1016/j.bbagen.2016.05.002_bb0065
  article-title: CD21 is a ligand for CD23 and regulates IgE production
  publication-title: Nature
  doi: 10.1038/358505a0
– volume: 62
  start-page: 1442
  year: 1988
  ident: 10.1016/j.bbagen.2016.05.002_bb0040
  article-title: Characterization of a T-lymphocyte Epstein–Barr virus/C3d receptor (CD21)
  publication-title: J. Virol.
  doi: 10.1128/JVI.62.4.1442-1447.1988
– volume: 140
  start-page: 126
  year: 1974
  ident: 10.1016/j.bbagen.2016.05.002_bb0050
  article-title: Role of complement in induction of antibody production in vivo Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.140.1.126
– volume: 158
  start-page: 1021
  year: 1983
  ident: 10.1016/j.bbagen.2016.05.002_bb0060
  article-title: Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.158.4.1021
– volume: 16
  start-page: 545
  year: 1998
  ident: 10.1016/j.bbagen.2016.05.002_bb0055
  article-title: The role of complement and complement receptors in induction and regulation of immunity
  publication-title: Annu. Rev. Immunol.
  doi: 10.1146/annurev.immunol.16.1.545
– volume: 40
  start-page: 5931
  year: 2001
  ident: 10.1016/j.bbagen.2016.05.002_bb0110
  article-title: Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg
  publication-title: Biochemistry
  doi: 10.1021/bi0101749
– volume: 167
  start-page: 1047
  year: 1988
  ident: 10.1016/j.bbagen.2016.05.002_bb0035
  article-title: Structure of the human B lymphocyte receptor for C3d and the Epstein–Barr virus and relatedness to other members of the family of C3/C4 binding proteins
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.167.3.1047
– volume: 23
  start-page: 327
  year: 1977
  ident: 10.1016/j.bbagen.2016.05.002_bb0155
  article-title: Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes
  publication-title: J. Comput. Phys.
  doi: 10.1016/0021-9991(77)90098-5
– volume: 82
  start-page: 11217
  year: 2008
  ident: 10.1016/j.bbagen.2016.05.002_bb0245
  article-title: Molecular basis of the interaction between complement receptor type 2 (cr2/cd21) and Epstein–Barr virus glycoprotein gp350
  publication-title: J. Virol.
  doi: 10.1128/JVI.01673-08
– volume: 22
  start-page: 184
  year: 1989
  ident: 10.1016/j.bbagen.2016.05.002_bb0170
  article-title: Free energy calculations: a breakthrough for modeling organic chemistry in solution
  publication-title: Acc. Chem. Res.
  doi: 10.1021/ar00161a004
– volume: 24
  start-page: 1999
  year: 2003
  ident: 10.1016/j.bbagen.2016.05.002_bb0180
  article-title: A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations
  publication-title: J. Comput. Chem.
  doi: 10.1002/jcc.10349
– volume: 33
  start-page: 889
  year: 2000
  ident: 10.1016/j.bbagen.2016.05.002_bb0210
  article-title: Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models
  publication-title: Acc. Chem. Res.
  doi: 10.1021/ar000033j
– volume: 79
  start-page: 926
  year: 1983
  ident: 10.1016/j.bbagen.2016.05.002_bb0145
  article-title: Comparison of simple potential functions for simulating liquid water
  publication-title: J. Chem. Phys.
  doi: 10.1063/1.445869
SSID ssj0000595
ssj0025309
Score 2.2090034
Snippet The interactions of complement receptor 2 (CR2) and the degradation fragment C3d of complement component C3 play important links between the innate and...
BACKGROUNDThe interactions of complement receptor 2 (CR2) and the degradation fragment C3d of complement component C3 play important links between the innate...
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2220
SubjectTerms Adaptive Immunity - immunology
Antigens - chemistry
Antigens - immunology
binding sites
Binding Sites - immunology
C3d
Complement
Complement C3 - chemistry
Complement C3 - immunology
Complement C3 - metabolism
CR2
Humans
immune system
Immunity, Innate - immunology
ionic strength
ions
Ions - chemistry
Ions - metabolism
MM-GBSA
molecular dynamics
Molecular Dynamics Simulation
Multiprotein Complexes - chemistry
Multiprotein Complexes - immunology
Multiprotein Complexes - metabolism
Osmolar Concentration
Protein Binding
Protein Conformation
Receptors, Complement 3d - chemistry
Receptors, Complement 3d - immunology
Receptors, Complement 3d - metabolism
solvents
vaccine development
Vaccines - chemistry
Vaccines - immunology
Title The solvent at antigen-binding site regulated C3d–CR2 interactions through the C-terminal tail of C3d at different ion strengths: insights from molecular dynamics simulation
URI https://dx.doi.org/10.1016/j.bbagen.2016.05.002
https://www.ncbi.nlm.nih.gov/pubmed/27154286
https://www.proquest.com/docview/1807280218
https://www.proquest.com/docview/1825432643
Volume 1860
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dT9swFLUQaNpeEGMfdDDkSXsNTRs7cXhD0VC3Ch7Y0HizbMfeOtEUNeGBl2n_YT-E_8Qv4d7Yhk3ahjSpUtTGjqzcG_ukPvccQt4aLVzNFcx-wuUJ00wnSiNpXChmAd4r0csXHx3nk1P24YyfrZAq1sIgrTLM_X5O72fr8Msw3M3hxWw2_IibegAnOCAKFI1BxU_GCszyve_3NA-AD9zvJLAEW8fyuZ7jpTU8tKiCOsr3fvlz5Q_L09_gZ78MHW6Q9YAf6YEf4lOyYptN8sg7Sl5tksdVNHB7Rq4hBSikFjIaqYJP06H0Jr4L44JFcd-YLr0Xva1pldU3P35WJ2OKEhJLX_DQ0mDkA0dLqyRwZ84pEk_pwmEvvHb0WekodKJYgNJ86b62-3CtFl__W4p1LHQezXhpfdWo-cy0MIp5cBB7Tk4P332qJknwZ0hMVvIucYAmam1UYctMWA5xdbrQxmjUwEedw7FhpXDcjjSrmVFMKZeaWpUuZ0VqbfaCrDaLxm4R6oQpmbFZqoyGc1yXOq0zCGo5YspwMyBZDIs0QbwcPTTOZWSpfZM-mBKDKVMuIZgDktz1uvDiHQ-0L2LE5W9JKGF9eaDnm5ggEqKMmy6qsYvLVo5Eig5ggKT-1QYlCQCaZgPy0mfX3XjHBYDcschf_ffYtskT_OYZiDtktVte2teApDq92z8qu2Tt4P10cozH6cnn6S2fryNF
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwEB6VrVC5ICh_2x8wEtew2Y2dONyqiGpL2z1AK_Vm2Y4Di7rZapMeeus78CC8E0_CTGK3IAGVkCKtlHgia2cy_hLPfB_AG2tkVQqN2U9WacQNN5E2VDQuNXcI77Xs6IuPZ-n0lH84E2drUIReGCqr9Lm_z-ldtvZnRv7fHF3M56NPtKmHcEIgoiDSmOQerBM7lRjA-t7B4XR2m5BFJ75C4yMyCB10XZmXMfjcEhHqOH37y_eVP6xQf0Og3Uq0_wgeegjJ9vpZPoY1V2_C_V5U8moTNoqg4fYEvmMUMIwuKmpkGo-6JfZNeh2mNYvR1jFb9XL0rmRFUv64_lZ8nDBikVj1PQ8N81o--OtYEfnymXNGtadsWZEV3TtIrbQMjRj1oNSf2y_NO7xXQ18AGkatLGwR9HhZeVXrxdw2OIuFFxF7Cqf770-KaeQlGiKb5KKNKgQUpbE6c3kinUDXViYz1hqiwSeqw4nluayEGxtecqu51lVsS51XKc9i55JnMKiXtXsBrJI259YlsbYGrwmTm7hM0K_5mGsr7BCS4BZlPX85yWicq1Co9lX1zlTkTBULhc4cQnRjddHzd9wxPgseV7_FocIl5g7L1yFAFHqZ9l107ZaXjRrLmETAEEz9awyxEiA6TYbwvI-um_lOMsS5E5lu_ffcXsHG9OT4SB0dzA634QFd6QsSd2DQri7dLgKr1rz0D85PXAUkUw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+solvent+at+antigen-binding+site+regulated+C3d%E2%80%93CR2+interactions+through+the+C-terminal+tail+of+C3d+at+different+ion+strengths%3A+insights+from+molecular+dynamics+simulation&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Zhang%2C+Yan&rft.au=Guo%2C+Jingjing&rft.au=Li%2C+Lanlan&rft.au=Liu%2C+Xuewei&rft.date=2016-10-01&rft.pub=Elsevier+B.V&rft.issn=0304-4165&rft.eissn=1872-8006&rft.volume=1860&rft.issue=10&rft.spage=2220&rft.epage=2231&rft_id=info:doi/10.1016%2Fj.bbagen.2016.05.002&rft.externalDocID=S0304416516301313
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon